Helper T cells play a key role in cell-mediated immunity by activating other immune cells such as B cells and cytotoxic T cells. When a macrophage or dendritic cell engulfs and displays antigens from an invading pathogen on its surface, it activates matching helper T cells. Once activated, helper T cells secrete cytokines that stimulate B cells to produce antibodies and activate cytotoxic T cells to destroy infected cells. Both cell-mediated and antibody-mediated immunity then work together to eliminate pathogens from the body. Memory cells are also generated to facilitate a faster response upon future encounters with the same pathogen.
It is fluid which is present
in the pericardial cavity of
heart b/w parietal pericardium n visceral pericardium.
The pericardial cavity is a
potential space lined by
mesothelium of the visceral n parietal pericardium.
RBC Indices- MCV, MCH, MCHC II Blood PhysiologyHM Learnings
RBC Indices- MCV, MCH, MCHC II Blood Physiology
The slide will cover the following:
1. Introduction to RBC indices
2. Mean Corpuscular volume (MCV)
3. Mean Corpuscular hemoglobin (MCH)
4. Mean Corpuscular hemoglobin concentration (MCHC)
5. Color index (CI)
You can also watch the same topic on HM Learnings Youtube channel.
You can also follow HM Learnings on facebook, instagram and twitter for daily updates
It is fluid which is present
in the pericardial cavity of
heart b/w parietal pericardium n visceral pericardium.
The pericardial cavity is a
potential space lined by
mesothelium of the visceral n parietal pericardium.
RBC Indices- MCV, MCH, MCHC II Blood PhysiologyHM Learnings
RBC Indices- MCV, MCH, MCHC II Blood Physiology
The slide will cover the following:
1. Introduction to RBC indices
2. Mean Corpuscular volume (MCV)
3. Mean Corpuscular hemoglobin (MCH)
4. Mean Corpuscular hemoglobin concentration (MCHC)
5. Color index (CI)
You can also watch the same topic on HM Learnings Youtube channel.
You can also follow HM Learnings on facebook, instagram and twitter for daily updates
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Coagulant & AntiCoagulant Haemostasis (arrest of blood loss) and blood coagulation involve complex interaction between the injury vessel wall, platelets and coagulation factors
This PPT is Second part of Hematology and covers the different concepts in Hematology. This includes functions of blood, components of blood, formation of blood cells, functions of RBC, WBC and Platelets, Eryhropoiesis, leucopoiesis and Synthesis of hemoglobin
This PPT covers the concepts of Lymphatic system and Immunity. This includes functions of Lymphatic system, components of Lymphatic system, Lymphatic organs and tissues, formation and flow of lymph and composition of Lymph
This PPT covers pathophysiology of thrombocytopenia which includes causes of thrombocytopenia, symptoms of thrombocytopenia and diagnosis of thrombocytopenia
This PPT covers leukocytosis and includes Types of leukocytosis-Neutrophilia, eosinophilia, basophilia, lymphocytosis and monocytosis, pathophysiology of leukocytosis, symptoms of leukocytosis and diagnosis of leukocytosis
This PPT covers the entire concepts in Muscular System. It includes details of 3 types of muscular tissue like Skeletal, cardiac and smooth muscle. Concepts of contraction cycle, sliding filament mechanism, neuromuscular junction, muscle metabolism, muscle tone and Different types of contraction.
This PPT covers drug therapy for tuberculosis. It includes classification of antitubercular drugs, chemotherapy for tuberculosis, strategies for addressing resistance and pharmacotherapy of antitubercular drugs
This PPT covers Drug therapy for Viral Infection or disease. It includes Viral replication cycle, classification of antiviral drugs, Anti-Herpes drug, Anti Influenza drugs, Anti hepatitis drugs and anti retroviral drugs
This PPT covers the Drug therapy for Malaria. This PPT includes Malaria cycle, different types of malaria , classification of antimalarial drugs and pharmacotherapy of all antimalarial drugs
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. HEMOSTASIS
HEMOSTASIS is the sequence of responses that stops bleeding
Three mechanisms reduce blood loss:
(1) Vascular Spasm,
(2) Platelet Plug Formation
(3) Blood Clotting (Coagulation).
Jegan
3. VASCULAR SPASM
When arteries or arterioles are damaged, the circularly arranged smooth muscle
in their walls contracts immediately
This reaction is called vascular spasm.
This reduces blood loss for several minutes to several hours, during which the
other hemostatic mechanisms go into operation
Jegan
5. 1. Platelet Adhesion
Initially, platelets contact and stick to parts of a damaged blood vessel, such as
collagen fibers of the connective tissue underlying the damaged endothelial
cells.
This process is called
platelet adhesion.
Jegan
6. 2. Platelet Release reaction
Due to adhesion, the platelets become activated.
They extend many projections that enable them to contact and interact with one
another.
They begin to liberate the contents of their vesicles.
This phase is called the platelet release reaction.
Liberated ADP and thromboxane A2 cause activation of nearby platelets.
Serotonin and thromboxane A2 function as vasoconstrictors.
Jegan
8. 3. Platelet Aggregation
The release of ADP makes other platelets in the area sticky
The stickiness cause newly recruited and activated platelets to adhere to the originally
activated platelets.
This gathering of platelets is called platelet
aggregation.
Eventually, the accumulation and attachment
of large numbers of platelets form a mass
called a platelet plug.
Jegan
9. BLOOD CLOTTING
The process of gel formation is called clotting or coagulation which is a series of
chemical reactions that result in formation of fibrin threads
Clotting involves several substances known as clotting (coagulation) factors.
These factors include calcium ions (Ca2), several inactive enzymes that are synthesized
by hepatocytes or released by damaged tissues
Clotting can be divided into three stages
Formation of prothrombinase
Prothrombinase converts prothrombin into thrombin
Thrombin converts fibrinogen into fibrin
Jegan
11. THE EXTRINSIC PATHWAY
The extrinsic pathway of blood clotting has fewer steps than the intrinsic pathway and
occurs rapidly
It is so named because a tissue protein called tissue factor (TF), also known as
thromboplastin leaks into the blood from cells outside blood vessels and initiates the
formation of prothrombinase
In the presence of Ca2, TF begins a sequence of reactions that ultimately activates
clotting factor X.
Once factor X is activated, it combines with factor V in the presence of Ca2 to form the
active enzyme prothrombinase, completing the extrinsic pathway.
Jegan
13. THE INTRINSIC PATHWAY
The intrinsic pathway of blood clotting is more complex than the extrinsic pathway.
It occurs more slowly, usually requiring several minutes.
The intrinsic pathway is so named because its activators are either in direct contact
with blood or contained within (intrinsic to) the blood
Jegan
14. If endothelial cells become roughened or damaged, blood come in contact with
collagen fibers.
In addition, trauma to endothelial cells causes damage to platelets, resulting in the
release of phospholipids by the platelets.
Contact with collagen fibers activates clotting factor XII, which begins a sequence of
reactions that eventually activates clotting factor X.
Once clotting factor X is activated, it combines with factor V to form the active enzyme
prothrombinase completing the intrinsic pathway.
Jegan
16. COMMON PATHWAY
The formation of prothrombinase marks the beginning of the common pathway.
In the second stage of blood clotting, prothrombinase and Ca2 catalyze the conversion
of prothrombin to thrombin.
In the third stage, thrombin, in the presence of Ca2, converts fibrinogen, which is
soluble, to loose fibrin threads, which are insoluble.
Thrombin also activates factor XIII (fibrin stabilizing factor), which strengthens and
stabilizes the fibrin threads into a sturdy clot.
Jegan
17. Thrombin has two positive feedback effects.
In the first positive feedback loop,
It involves factor V, it accelerates the formation of prothrombinase.
Prothrombinase in turn accelerates the production of more thrombin, and so on.
In the second positive feedback loop
Thrombin activates platelets, which reinforces their aggregation and the release of
platelet phospholipids.
Jegan
18. CLOT RETRACTION
Once a clot is formed, it plugs the ruptured area of the blood vessel and thus stops
blood loss.
Clot retraction is the consolidation or tightening of the fibrin clot.
The fibrin threads attached to the damaged surfaces of the blood vessel gradually
contract as platelets pull on them.
As the clot retracts, it pulls the edges of the damaged vessel closer together, decreasing
the risk of further damage.
During retraction, some serum can escape between the fibrin threads, but the formed
elements in blood cannot.
Jegan
21. BLOOD GROUPS
There are at least 24 blood groups
More than 100 antigens that can be detected on the surface of red blood
cells.
Two major blood groups—ABO and Rh system.
Other blood groups include the Lewis, Kell, Kidd, and Duffy systems.
Jegan
24. Rh SYSTEM
The Rh blood group is so named because the Rh antigen, called Rh factor, was first
found in the blood of the Rhesus monkey.
People whose RBCs have Rh antigens are designated Rh+ (Rh positive); those who lack
Rh antigens are designated Rh- (Rh negative).
Normally, blood plasma does not contain anti-Rh antibodies.
Jegan
25. Rh SYSTEM
If an Rh- person receives an Rh+ blood transfusion, however, the immune system starts
to make anti-Rh antibodies that will remain in the blood.
If a second transfusion of Rh- blood is given later, the previously formed anti-Rh
antibodies will cause agglutination and hemolysis of the RBCs in the donated blood,
and a severe reaction may occur.
Jegan
27. TRANSFUSION
A transfusion is the transfer of whole blood or blood components (red blood cells only
or blood plasma only) into the bloodstream or directly into the red bone marrow.
In an incompatible blood transfusion, antibodies in the recipient’s plasma bind to the
antigens on the donated RBCs, which causes agglutination or clumping, of the RBCs.
Agglutination is an antigen–antibody response in which RBCs become cross-linked to
one another
Jegan
28. When these antigen–antibody complexes form, they activate plasma proteins of the
complement family
In essence, complement molecules make the plasma membrane of the donated RBCs
leaky, causing hemolysis or rupture of the RBCs and the release of hemoglobin into
the blood plasma.
The liberated hemoglobin may cause kidney damage by clogging the filtration
membranes
Jegan
30. What is Immunity??
It is the ability of an
organism to resist a
particular infection or
toxin by the action of
antibodies or white blood
cells
Jegan
32. INNATE IMMUNITY
Innate immunity is nonspecific defense mechanisms that come into play
immediately or within hours of an antigen's appearance in the body.
These mechanisms include
Physical barriers such as Skin,
Chemicals in the blood
Immune system cells that attack foreign cells in the body.
Jegan
36. Second Line of Defense: Internal Defenses
When pathogens penetrate the physical and chemical barriers of the skin and
mucous membranes, they encounter a second line of defense:
Internal antimicrobial substances,
Phagocytes,
Natural killer cells,
Inflammation,
Fever.
Jegan
37. Antimicrobial Substances
There are four main types of antimicrobial substances that discourage
microbial growth:
1. Interferons,
2. Complement system
3. Iron-binding proteins, and
4. Antimicrobial proteins.
Jegan
38. 1. INTERFERON
Cells infected with viruses produce proteins called interferons or IFNs.
Once released by virus-infected cells, IFNs diffuse to uninfected neighboring
cells.
There they induce synthesis of antiviral proteins that interfere with viral
replication
Jegan
41. 2. COMPLIMENT SYSTEM
A group of normally inactive proteins in blood plasma and on the plasma membranes
makes up the complement system.
Bacterial cell wall made up of carbohydrate
Complement protein attaches to specific carbohydrate chain on bacterial wall and leads
to formation of membrane attack complex
Membrane attack complex are nothing but pores on the surface
This cause the outside fluid to enter bacterial cell
Because of this bacterial cell will burst (cytolysis)
Jegan
43. 3. IRON-BINDING PROTEINS
Iron-binding proteins inhibit the growth of certain bacteria by reducing the
amount of available iron.
Examples include
Transferrin (found in blood and tissue fluids),
Lactoferrin (found in milk, saliva, and mucus),
Ferritin (found in the liver, spleen, and red bone marrow)
Hemoglobin (found in red blood cells).
Jegan
44. 4. ANTIMICROBIAL PROTEINS (AMPS)
Antimicrobial proteins (AMPs) are short peptides that have a broad
spectrum of antimicrobial activity.
Examples of AMPs are
Dermicidin (produced by sweat glands),
Defensins and cathelicidins (produced by neutrophils, macrophages
and epithelial cells
Thrombocidin (produced by platelets).
Jegan
45. NATURAL KILLER CELLS
About 5–10% of lymphocytes in the blood are natural killer (NK) cells
The NK cells bind to a target cell and cause the release of granules containing toxic
substances from NK cells
Some granules contain a protein called perforin that inserts into the plasma membrane
of the target cell and creates channels (perforations) in the membrane.
As a result, extracellular fluid flows into the target cell and,the cell bursts, a process
called cytolysis
Other granules of NK cells release granzymes, which are protein-digesting enzymes
that induce the target cell to undergo apoptosis, or self-destruction
Jegan
46.
47. PHAGOCYTES
Phagocytes are specialized cells that perform phagocytosis, the ingestion of microbes
or other particles such as cellular debris
The two major types of phagocytes are neutrophils and macrophages
When an infection occurs, neutrophils and monocytes migrate to the infected area.
During this migration, the monocytes enlarge and develop into actively phagocytic
macrophages called wandering macrophages.
Fixed macrophages
Jegan
49. FEVER
Fever is an abnormally high body temperature that occurs because the hypothalamic
thermostat is reset.
It commonly occurs during infection and inflammation.
Bacterial toxins elevate body temperature, by triggering release of fever-causing
cytokines
Elevated body temperature
Intensifies the effects of interferons,
Inhibits the growth of some microbes,
Speeds up body reactions that aid repair. Jegan
50. ADAPTIVE/ AQUIRED IMMUNITY
The ability of the body to defend itself against specific invading agents such as bacteria,
toxins, viruses, and foreign tissues is called adaptive (specific) immunity.
Two properties distinguish adaptive immunity from innate immunity:
Specificity for particular foreign molecules (antigens)
Memory for most previously encountered antigens so that a second encounter
prompts an even more rapid and vigorous response
Jegan
51. White blood cells called lymphocytes originate in the bone marrow but migrate to
parts of the lymphatic system such as the lymph nodes, spleen, and thymus for
further development
There are two main types of lymphatic cells, T cells and B cells.
Adaptive immunity involves lymphocytes called B cells and T cells.
Jegan
52. On the surface of each lymphatic cell are receptors that enable them to recognize
foreign substances. These receptors are very specialized - each can match only one
specific antigen
Jegan
53. TYPES OF ADAPTIVE IMMUNITY
There are two types of adaptive immunity:
Cell-mediated immunity
Humoral immunity (Antibody-mediated immunity)
Both types of adaptive immunity are triggered by antigens.
In cell-mediated immunity, cytotoxic T cells directly attack invading antigens.
In antibody-mediated immunity, B cells transform into plasma cells, which synthesize
and secrete specific proteins called antibodies (Abs) or immunoglobulins (Igs)
Jegan
54. In most cases, when a particular antigen initially enters the body, there is only a small
group of lymphocytes with the correct antigen receptors to respond to that antigen
Depending on its location, a given antigen can provoke both types of adaptive immune
responses.
Some copies of the antigen may be present inside body cells (which provokes a cell-
mediated immune response)
While other copies of the antigen may be present in extracellular fluid (which provokes
an antibody-mediated immune response).
Thus, cell-mediated and antibody-mediated immune responses often work together to
get rid of the large number of copies of a particular antigen from the body.
Jegan
55. CELL-MEDIATED IMMUNITY
Cell-mediated immunity is an immune response that does not involve antibodies, but
rather involves the activation of phagocytes, helper T cells, antigen-specific cytotoxic T-
lymphocytes, and the release of various cytokines in response to an antigen.
Cell-mediated immunity is particularly effective against
Intracellular pathogens, which include any viruses, bacteria, or fungi that are
inside cells
Some cancer cells
Foreign tissue transplants
Jegan
56. Cell mediated immunity involves T-cells
They are named T cells after the thymus, an organ situated under the breastbone.
T cells are produced in the bone marrow and later move to the thymus where they
mature.
There are two major types of mature T cells
Helper T cells are also known as CD4 T cells, which means that, their plasma
membranes include a protein called CD4.
Cytotoxic T cells are also referred to as CD8 T cells because their plasma
membranes contain a protein known as CD8.
Jegan
57. When antigen invades a body they are present in huge number throughout the body
But to this specific antigen there is less number of T-cells and B-cells
Therefore, once each of these lymphocytes undergoes clonal selection.
Clonal selection is the process by which a lymphocyte proliferates (divides) and
differentiates (forms more highly specialized cells) in response to a specific antigen.
The result of clonal selection is the formation of a population of identical cells, called a
clone, that can recognize the same specific antigen as the original lymphocyte
Jegan
59. HELPER T-CELLS
Helper T cells are the major driving force and the main regulators of the immune
defense.
Their primary task is to activate B cells and killer T cells.
However, the helper T cells themselves must be activated.
Jegan
60. This happens when a macrophage or dendritic cell, which has eaten an invader, travels
to the nearest lymph node to present information about the captured pathogen.
The phagocyte displays an antigen fragment from the invader on its own surface, a
process called antigen presentation.
When the receptor of a helper T cell recognizes the antigen, the T cell is activated.
Once activated, helper T cells start to divide and to produce proteins that activate B and
T cells as well as other immune cells.
Jegan
62. CYTOTOXIC T CELL (KILLER T CELL)
The Cytotoxic T cell (killer T cell) is specialized in attacking cells of the body infected by
viruses and sometimes also by bacteria.
It can also attack cancer cells.
The killer T cell has receptors that are used to search each cell that it meets.
If a cell is infected, it is swiftly killed.
Infected cells are recognized because tiny traces of the intruder, antigen, can be found
on their surface
Jegan
64. HUMORAL IMMUNITY (ANTIBODY-MEDIATED IMMUNITY)
Humoral immunity is the aspect of immunity that is mediated by macromolecules
found in extracellular fluids such as secreted antibodies, complement proteins, and
certain antimicrobial peptides.
Humoral immunity is so named because it involves substances found in the humors, or
body fluids
In Humoral immunity (antibody-mediated immunity), B cells transform into plasma
cells, which synthesize and secrete specific proteins called antibodies (Abs) or
immunoglobulins (Igs)
Jegan
65. The B lymphocyte cell searches for antigen matching its receptors.
If it finds such antigen it connects to it, and inside the B cell a triggering
signal is set off.
The B cell now needs proteins produced by helper T cells to become fully
activated.
When this happens, the B cell starts to divide to produce clones of itself.
During this process, two new cell types are created, plasma cells and B
memory cells
Jegan
66. PLASMA B-CELL
The plasma cell is specialized in producing a specific protein, called an antibody, that will
respond to the same antigen that matched the B cell receptor.
Antibodies are released from the plasma cell so that they can destroy invader cells.
Plasma cells produce antibodies at an amazing rate and can release thousands of antibodies
per second.
When the Y-shaped antibody finds a matching antigen, it attaches to it.
The attached antibodies serve as an appetizing coating for eater cells such as the macrophage.
Antibodies also neutralize toxins and incapacitate viruses, preventing them from infecting new
cells.
Jegan
67. MEMORY B-CELLS
The Memory Cells are the second cell type produced by the division of B cells.
These cells have a prolonged life span and can thereby "remember" specific intruders.
T cells can also produce memory cells with an even longer life span than B memory cells.
The second time an intruder tries to invade the body, B and T memory cells help the
immune system to activate much faster.
The invaders are wiped out before the infected human feels any symptoms.
The body has achieved immunity against the invader.
Jegan